
    
      The primary objective of this study is to evaluate the safety and tolerability of CCX140-B in
      subjects with diabetic nephropathy based on subject incidence of adverse events.

      The secondary objectives of this study include evaluation of the effect of CCX140-B on
      several measures of effectiveness commonly used in the evaluation of diabetes and renal
      medications.
    
  